ANGO
AngioDynamics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ANGO Filings
Filing Date
Form Description
Form Type
2025-11-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-12
Form 8-K - Current report
Key Events
2025-11-12 · Key Events
Form 8-K - Current report
2025-10-22
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-10-22 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-10-21
Form S-8 - Securities to be offered to employees in employee benefit plans
Ownership
2025-10-21 · Ownership
Form S-8 - Securities to be offered to employees in employee benefit plans
2025-10-14
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-10-14 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-10-09
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-10-09 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-10-02
AngioDynamics, Inc. (ANGO) Q1 2026 Earnings Call Transcript
Earnings Call
2025-10-02 · Earnings Call
AngioDynamics, Inc. (ANGO) Q1 2026 Earnings Call Transcript
2025-10-02
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-10-02 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-10-02
Form 8-K - Current report
Key Events
2025-10-02 · Key Events
Form 8-K - Current report
2025-09-25
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Key Events
2025-09-25 · Key Events
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
